Markets
← Back to Stocks
ZTS
ZOETIS INC
Health Care · Pharmaceuticals
$116.01
-1.47%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
Zoetis to acquire Neogen animal genomics business for $160M, enhancing precision health capabilities in genomics space
Zoetis announced acquisition of Neogen's animal genomics business for $160 million, expected to close in H2 2026, adding five global laboratories and expanding genotyping, sequencing, and software capabilities in precision animal health. The stock closed at $127.17 yesterday and declined marginally 0.19% in after-hours to $126.92 and 0.13% in pre-market to $127.02, showing resilience despite the acquisition announcement requiring integration planning. The acquisition positions Zoetis to enhance competitive positioning in the fast-growing precision animal health market.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$51.1B
P/E (TTM)19.3
Forward P/E15.4
Beta0.95
Div Yield181.00%
Prev Close$117.74
RSI (14-Day)
24Oversold
0305070100
52-Week Range
$114.47$116.01$172.23
From High-32.6%
From Low+1.3%
Moving Averages
50d SMA
$124.53-6.8%
200d SMA
$137.79-15.8%
Price below 200d MA — bearish structure.
Returns
1W
+0.5%
1M
-10.2%
3M
-5.5%
6M
-20.4%
1Y
-28.4%
YTD
-7.5%
Volume
Today109K
20d Avg3.9M
Ratio0.03x